The 5′ untranslated regions (UTRs) of CCN1, CCN2, And CCN4 exhibit cryptic promoter activity

Journal of Cell Communication and Signaling

Volumn 1, Issue 1, 2007, Pages 17-32

  Huang, Bau Lin ^a   Dornbach, Lisa M ^b   Lyons, Karen M ^c  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCN1 (Cyr61); CCN2 (CTGF); CCN4 (WISP 1); Cryptic promoter; IRES

Indexed keywords

EID: 73549110023     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-007-0003-1     Document Type: Article

References (71)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-beta. Nat Cell Biol 4:599–604
2. Baird SD, Turcotte M, Korneluk RG, Holcik M (2006) Searching for IRES. RNA 12:1755–1785
3. Bert AG, Grepin R, Vadas MA, Goodall GJ (2006) Assessing IRES activity in the HIF-1alpha and other cellular 5′ UTRs. RNA 12:1074–1083
4. Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608–616
5. Brigstock D (2003) The CCN family: a new stimulus package. J Endocrinol 178:169–175
6. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engstrom PG, Frith MC et al (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38:626–635
7. Englander EW, Widen SG, Wilson SH (1991) Mammalian betapolymerase promoter: phosphorylation of ATF/CRE-binding protein and regulation of DNA binding. Nucleic Acids Res 19:3369–3375
8. French DM, Kaul RJ, D'Souza AL, Crowley CW, Bao M, Frantz GD, Filvaroff EH, Desnoyers L (2004) WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165:855–867
9. Friedrichsen S, Heuer H, Christ S, Winckler M, Brauer D, Bauer GR (2003) CTGF expression during mouse embryonic development. Exp Cell Res 312:175–188
10. Frith MC, Hansen U, Weng Z (2001) Detection of cis-element clusters in higher eukaryotic DNA. Bioinformatics 17:878–889
11. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP (2005) Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11:7243–7254
12. Han B, Zhang JT (2002) Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story. Mol Cell Biol 22:7372–7384
13. Hellen CU, Sarnow P (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593–1612
14. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH (2004) Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223–F1232
15. Holcik M, Graber T, Lewis SM, Lefebvre CA, Lacasse E, Baird S (2005) Spurious splicing within the XIAP 5′ UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system. RNA 11:1605–1609
16. Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, Black CM, Leask A (2003) Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 278:41728–41733
17. Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS (2006) Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 146:362–370
18. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM, Herd JK, Van Hul EV et al (1999) Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 23:94–98
19. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K, Okada Y (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16:219–221
20. Ivkovic S, Yoon B, Popoff S, Safadi F, Libuda D, Stephenson R, Daluiski A, Lyons K (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791
21. Johannes G, Carter MS, Eisen MB, Brown PO, Sarnow P (1999) Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc Natl Acad Sci U S A 96:13118–13123
22. Kasaragod AB, Lucia MS, Cabirac G, Grotendorst GR, Stenmark KR (2001) Connective tissue growth factor expression in pediatric myofibroblastic tumors. Pediatr Dev Pathol 4:37–45
23. Kim SW, Lee SH, Kim KS, Kim CH, Choo YK, Lee YC (2002) Isolation and characterization of the promoter region of the human GM3 synthase gene. Biochim Biophys Acta 1578:84–89
24. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B (2005) A high-resolution map of active promoters in the human genome. Nature 436:876–880
25. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H et al (2006) Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 16:55–65
26. Komar AA, Hatzoglou M (2005) Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J Biol Chem 280:23425–23428
27. Kondo S, Kubota S, Mukudai Y, Moritani N, Nishida T, Matsushita H, Matsumoto S, Sugahara T, Takigawa M (2006) Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3′-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 25:1099–1110
28. Kozak M (2005) A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res 33:6593–6602
29. Kraggerud SM, Sandvik JA, Pettersen EO (1995) Regulation of protein synthesis in human cells exposed to extreme hypoxia. Anticancer Res 15:683–686
30. Kubota S, Mukudai Y, Moritani NH, Nakao K, Kawata K, Takigawa M (2005) Translational repression by the cis-acting element of structure-anchored repression (CAESAR) of human ctgf/ccn2 mRNA. FEBS Lett 579:3751–3758
31. Kunz M, Moeller S, Koczan D, Lorenz P, Wenger RH, Glocker MO, Thiesen HJ, Gross G, Ibrahim SM (2003) Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 278:45651–45660
32. Lau L, Lam S (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248:44–57
33. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803–4810
34. Li V, Raouf A, Kitching R, Seth A (2004) Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation. In Vivo 18:517–524
35. Liu B, Yu J, Taylor L, Zhou X, Polgar P (2006) Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J Cell Biochem 97:1104–1120
36. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC (2004) Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131:2137–2147
37. Michiels C (2003) Endothelial cell functions. J Cell Physiol 196: 430–443
38. Mo F-E, Muntean A, Chen C-C, Stolz D, Watkins S, Lau L (2002) CYR61 (CCN1) is essential from placental development and vascular integrity. Mol Cell Biol 22:8709–8720
39. Nakanishi T, Yamaai T, Asano M, Nawachi K, Suzuki M, Sugimoto T, Takigawa M (2001) Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. Biochem Biophys Res Commun 281:678–681
40. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17–29
41. Olbryt M, Jarzab M, Jazowiecka-Rakus J, Simek K, Szala S, Sochanik A (2006) Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro. Gene Expr 13:191–203
42. Pan LH, Beppu T, Kurose A, Yamauchi K, Sugawara A, Suzuki M, Ogawa A, Sawai T (2002) Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res 24:677–683
43. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M et al (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95:14717–14722
44. Planque N, Perbal B (2003) A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 3:15
45. Rachfal AW, Brigstock DR (2005) Structural and functional properties of CCN proteins. Vitam Horm 70:69–103
46. Raouf A, Seth A (2000) Ets transcription factors and targets in osteogenesis. Oncogene 19:6455–6463
47. Sandelin A, Wasserman WW, Lenhard B (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 32:W249–W252
48. Schibler U, Sierra F (1987) Alternative promoters in developmental gene expression. Annu Rev Genet 21:237–257
49. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001) Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865–2876
50. Schneider R, Agol VI, Andino R, Bayard F, Cavener DR, Chappell SA, Chen JJ, Darlix JL, Dasgupta A, Donze O et al (2001) New ways of initiating translation in eukaryotes. Mol Cell Biol 21:8238–8246
51. Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE (2004) BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem 279:29066–29074
52. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T, Takigawa M (2001) Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 174:57–64
53. Smale ST, Kadonaga JT (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72:449–479
54. Stoneley M, Paulin FE, Le Quesne JP, Chappell SA, Willis AE (1998) C-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene 16:423–428
55. Stoneley M, Subkhankulova T, Le Quesne JP, Coldwell MJ, Jopling CL, Belsham GJ, Willis AE (2000) Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment. Nucleic Acids Res 28:687–694
56. Stoneley M, Willis AE (2004) Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23:3200–3207
57. Takigawa M (2003) CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect 16:11–21
58. Tinton SA, Buc-Calderon PM (1999) Hypoxia increases the association of 4E-binding protein 1 with the initiation factor 4E in isolated rat hepatocytes. FEBS Lett 446:55–59
59. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A (1992) Internal ribosome entry site within hepatitis C virus RNA. J Virol 66:1476–1483
60. Tullai JW, Schaffer ME, Mullenbrock S, Kasif S, Cooper GM (2004) Identification of transcription factor binding sites upstream of human genes regulated by the phosphatidylinositol 3-kinase and MEK/ERK signaling pathways. J Biol Chem 279:20167–20177
61. Vagner S, Galy B, Pyronnet S (2001) Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep 2:893–898
62. Van Eden ME, Byrd MP, Sherrill KW, Lloyd RE (2004a) Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. RNA 10:720–730
63. Van Eden ME, Byrd MP, Sherrill KW, Lloyd RE (2004b) Translation of cellular inhibitor of apoptosis protein 1 (c-IAP1) mRNA is IRES mediated and regulated during cell stress. RNA 10:469–481
64. Wong M, Kireeva ML, Kolesnikova TV, Lau LF (1997) Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol 192:492–508
65. Wu L, Kobayashi K, Sun T, Gao P, Liu J, Nakamura M, Weisberg E, Mukhopadhyay NK, Griffin JD (2004) Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. Gene 328:153–165
66. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61:8917–8923
67. Xu L, Corcoran R, Welsh J, Pennica D, Levine A (2000) WISP-1 is a Wnt-1- and β-catenin-responsive oncogene. Genes Dev 14: 585–595
68. Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E (2007) Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389:52–65
69. Yu C, Le AT, Yeger H, Perbal B, Alman BA (2003) NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol 201:609–615
70. Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR (2004) VEGFA is necessary for chondrocyte survival during bone development. Development 131:2161–2171
71. Zeng ZJ, Yang LY, Ding X, Wang W (2004) Expressions of cysteinerich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J Gastroenterol 10:3414–3418